ConductScience.org, home

Paper874697

The pharmacokinetics of amikacin in children.

Vogelstein B and 2 others. J Pediatr, 1977. Cited by 65 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The pharmacokinetics of amikacin in children. Papers, record 874697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/874697

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pharmacokinetics of amikacin in children.
PubMed
Journal
J Pediatr
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
3.54
iCite
Revised in PubMed
2019-06-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vogelstein BB
2Kowarski AA
3Lietman PSP S

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmikacinMajor topic
KanamycinMajor topic
Metabolic Clearance RateMajor topic
Adolescent
Anemia, Aplastic
Appendicitis
Child
Child, Preschool
Cystic Fibrosis
Female
Half-Life
Humans
Kidney
Leukemia
Male
Neoplasms
Neutropenia
Pelvic Inflammatory Disease

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
39435440Prediction of tissue exposures of polymyxin-B, amikacin and sulbactam using physiologically-based pharmacokinetic modeling.Front Microbiol2024https://conductscience.org/library/papers/39435440PubMed
34185905Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in Children.J Clin Pharmacol2021https://conductscience.org/library/papers/34185905PubMed
33498481Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients.Antibiotics (Basel)2021https://conductscience.org/library/papers/33498481PubMed
26801317Prediction of Human Glomerular Filtration Rate from Preterm Neonates to Adults: Evaluation of Predictive Performance of Several Empirical Models.AAPS J2016https://conductscience.org/library/papers/26801317PubMed
21190043Renal function in pediatric cystic fibrosis patients in the first decade of life.Pediatr Nephrol2011https://conductscience.org/library/papers/21190043PubMed
9884816Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.Clin Pharmacokinet1998https://conductscience.org/library/papers/9884816PubMed
8055682Pharmacokinetics of anti-infective agents in paediatric patients.Clin Pharmacokinet1994https://conductscience.org/library/papers/8055682PubMed
7327659Newer antibiotics.Indian J Pediatr1981https://conductscience.org/library/papers/7327659PubMed
7140805Modification in the pharmacokinetics of amikacin during development.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7140805PubMed
4083865Pharmacokinetics and dosage requirements of netilmicin in cystic fibrosis patients.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4083865PubMed
3780832Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3780832PubMed
3319914High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.Infection1987https://conductscience.org/library/papers/3319914PubMed
3311531Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.Clin Pharmacokinet1987https://conductscience.org/library/papers/3311531PubMed
3293970Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.Drugs1988https://conductscience.org/library/papers/3293970PubMed
3117703Kinetic parameters of amikacin in cystic fibrosis children.Infection1987https://conductscience.org/library/papers/3117703PubMed
3042246Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.Clin Pharmacokinet1988https://conductscience.org/library/papers/3042246PubMed
2802567Pharmacokinetics of amikacin in hematologic malignancies.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2802567PubMed
2327775Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2327775PubMed
533263Amikacin pharmacokinetics in pediatric patients with malignancy.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/533263PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/874697

GET https://conductscience.org/api/papers/v1/874697/authors